Article Information
History
- November 2, 2021.
Article Versions
- Version 1 (July 6, 2021 - 10:42).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Amandine Gagneux-Brunon1,2,3,4,*,
- Elisabeth Botelho-Nevers1,2,3,
- Marion Bonneton4,
- Patrick Peretti-Watel,
- Pierre Verger6,
- Odile Launay4,5 and
- Jeremy K. Ward7,8
- 1Centre International de Recherche en Infectiologie, Team GIMAP, Univ Lyon, Université Jean Monnet, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR530
- 2CIC INSERM 1408 Vaccinologie, CHU de Saint-Etienne, France
- 3Chaire PREVACCI, Université Jean Monnet, Saint-Etienne, France
- 4Inserm, F-CRIN, I-REIVAC/COVIREIVAC, 75679 Paris, France
- 5Université de Paris ; Inserm CIC 1417 ; Assistance publique – Hôpitaux de Paris, hôpital Cochin, 75679 Paris, France
- 6Observatoire régional de la santé Paca, Marseille, France
- 7VITROME (Aix Marseille Université, IRD, AP-HM, SSA), Marseille, France
- 8CERMES3 (INSERM, CNRS, EHESS, Université de Paris), Villejuif, France
- ↵*Corresponding author : Dr Amandine Gagneux-Brunon, MD-Ph-D, amandine.gagneux-brunon{at}chust-etienne.fr